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Introduction
Chronic obstructive pulmonary disease (COPD) is caused by the 
noxious effects of tobacco smoke, which leads to airway epithe-
lial cell injury and the induction of phenotypic changes such as 
squamous metaplasia and cellular senescence, which are assumed 
to be part of the adaptive response to toxic components such as 
reactive oxygen species (ROS).1 Recently, accelerated cell senes-
cence has been demonstrated in COPD airway and lung and is 
now widely implicated in pathogenesis of COPD in terms of not 
only impaired cell repopulation following apoptotic cell loss but 
also aberrant cytokine secretions of senescence-associated secre-
tory phenotype (SASP).2,3 SASP exert deleterious effects on the 
tissue microenvironment of neighboring cells, resulting in can-
cer development.4,5 Indeed, epidemiological studies indicate that 
COPD is one of the most important risk factors for lung cancer 
after smoking exposure, with airway inflammation as a mecha-
nism for lung cancer recently proposed.6,7
Tobacco smoke-induced accelerated cell senescence has been implicated in the pathogenesis of chronic obstructive 
pulmonary disease (cOpD). cell senescence is accompanied by the accumulation of damaged cellular components 
suggesting that in cOpD, inhibition of autophagy may contribute to cell senescence. here we look at whether autophagy 
contributes to cigarette smoke extract (cse)-induced cell senescence of primary human bronchial epithelial cells (hBec), 
and further evaluate p62 and ubiquitinated protein levels in lung homogenates from cOpD patients. We demonstrate 
that cse transiently induces activation of autophagy in hBec, followed by accelerated cell senescence and concomitant 
accumulation of p62 and ubiquitinated proteins. autophagy inhibition further enhanced accumulations of p62 and 
ubiquitinated proteins, resulting in increased senescence and senescence-associated secretory phenotype (sasp) 
with interleukin (IL)-8 secretion. conversely, autophagy activation by Torin1, a mammalian target of rapamycin (mTOR 
inhibitor), suppressed accumulations of p62 and ubiquitinated proteins and inhibits cell senescence. Despite increased 
baseline activity, autophagy induction in response to cse was significantly decreased in hBec from cOpD patients. 
Increased accumulations of p62 and ubiquitinated proteins were detected in lung homogenates from cOpD patients. 
Insufficient autophagic clearance of damaged proteins, including ubiquitinated proteins, is involved in accelerated 
cell senescence in cOpD, suggesting a novel protective role for autophagy in the tobacco smoke-induced senescence-
associated lung disease, cOpD.
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Tobacco smoke induces both cell division-dependent replica-
tive senescence, (linked to telomere shortening), as well as stress-
induced premature senescence.8 The molecular mechanisms 
for regulation of cell senescence are complex and incompletely 
understood, but are generally thought to result from increased 
oxidative stress. One of the typical manifestations of cell senes-
cence is accumulation of damaged proteins and organelles, occa-
sionally associated with ubiquitinated aggregations.9 It has been 
widely proposed that the functional insufficiency of cellular 
cleaning and housekeeping mechanisms for protein and organ-
elle degradation, including proteasome and autophagy pathways, 
play a pivotal role in the accumulations of deleterious cellular 
components and regulation of cell senescence.9,10
Proteasomes, with a narrow range of catalytic pore size, restricts 
the clearance of ubiquitin-conjugated soluble proteins, whereas 
autophagy is responsible for the degradation of aggregate-prone 
proteins and damaged organelles, suggesting the predominant 
contribution of autophagy to the regulation of cell senescence.11 
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of binding both polyubiquitinated sub-
strates and Atg8/LC3, an indispensable 
component for autophagosome forma-
tion, and hence is thought to play a key 
regulatory role in the delivery of ubiqui-
tinated proteins for selective autophagic 
degradation. Therefore, accumulation 
of p62 and ubiquitinated proteins is 
proposed to be a representative indica-
tor of insufficient autophagic clearance.
Collectively, it is reasonable to 
hypothesize that insufficiency of 
autophagic degradation of damaged 
proteins and organelles may be involved 
in the acceleration of cell senescence 
caused by tobacco smoke exposure. 
Recent studies have demonstrated that 
increased activation of autophagy occurs 
in lungs of patients with COPD, and 
concomitant induction of apoptosis was 
implicated in a part of the pathogenic 
sequence for COPD development.14 
However, the implication of tobacco 
smoke exposure-induced autophagic 
regulation in clearance of damaged 
proteins for the regulation of human 
bronchial epithelial cell (HBEC) senes-
cence has not been elucidated. In this 
context, we examined the regulatory 
role of autophagy in cigarette smoke 
extract (CSE)-induced cell senescence 
of primary HBEC.
Results
CSE transiently induces autophagy 
activation in human bronchial epi-
thelial cells. Western blotting for the 
conversion of LC3 from LC3-I (free 
form) to LC3-II (phosphatidylethanol-
amine-conjugated form) and detection 
of EGFP-LC3 dot formation by fluo-
rescence microscopy were performed to 
evaluate the activation of autophagy.15 
CSE significantly activated autoph-
agy in BEAS-2B cells, consistent with 
previous reports (Fig. 1A and B).14 
Treatment with rapamycin alone, an 
mTOR inhibitor, increased autophagy 
activation to a similar level as that of CSE (Fig. 1A), as previously 
described.16 CSE and bafilomycin A, an autophagy inhibitor via 
lysosomal proton pump inhibition, clearly induced EGFP-LC3 
dot formation. CSE also induced autophagy in HBEC, which 
peaked 12–24 h after treatment and was barely detected after 
36 h (Fig. 1C), indicating that CSE-induced autophagy was 
transient.
Autophagy, a lysosomal degradation pathway, occurs not only 
continuously at basal levels for homeostatic turnover of cytoplas-
mic components but is also induced in response to a variety of 
stress stimuli including oxidative stress.12 Recent studies revealed 
interactions between the proteasome and autophagy pathways 
during degradation of ubiquitinated proteins by autophagy.13 
p62/SQSTM1 has been shown to be an adaptor protein capable 
Figure 1. autophagy activation in response to cse exposure. (a) Western blotting (WB) using anti-
Lc3 and anti-β-actin in control treated (lanes 1 and 2), rapamycin treated (1 μM) (lanes 3 and 4), cse 
treated (lanes 5 and 6) in the presence or absence of protease inhibitors (e64d 10 μg/ml and pep-
statin a 10 μg/ml) in Beas2B cells. protein samples were collected after 24 h treatment with indicated 
concentrations of cse. shown is a representative experiment of three similar results. The right part 
is the densitometric analysis of WB from three independent experiments. Lc3-II/β-actin in the pres-
ence of protease inhibitors was subtracted by Lc3-II/β-actin without protease inhibitors. *p < 0.05. 
(B) Fluorescence microscopic detection of peGFp-Lc3 dot formation in Beas-2B cells: Beas-2B cells 
with stable expression of peGFp-Lc3 were treated with bafilomycin a (200 nM), cse (1.0%) or both 
bafilomycin a and cse for 24 h. photomicrographs are taken at the same magnification. (Original 
magnification, 1,000×) Bar = 10 μm. The right part is the percentage of positive cells with more than 
five dot formations and data were collected from three independent experiments. *p < 0.05. (c) WB 
using anti-Lc3 and anti-β-actin for indicated time points of control or cse (1.0%) treatment in the 
presence of protease inhibitors (e64d and pepstatin a) in hBec from non-cOpD patients. cse treat-
ment was started from 0 h to sample collection and protease inhibitors were added during indicated 
time period. shown is a representative experiment of three similar results. The right part is the rela-
tive increase of Lc3-II after cse exposure taken from densitometric analysis of WB. *p < 0.05.
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To elucidate the involvement of p62 in ubiquitinated pro-
tein accumulation in the progression of cellular senescence, we 
employed p62 siRNA. HBECs were transfected with siRNA 
targeting p62 and RT-PCR and WB analysis 48 h after trans-
fection showed that p62 siRNA very efficiently reduced the 
amount of p62 mRNA and protein (Fig. 4E). Knock-down of 
p62 did not effect CSE-induced accumulation of ubiquitinated 
proteins and cell senescence (Fig. 4F and G). Interestingly, 
p62 knockdown led to a slight but insignificant suppres-
sion of senescence both in the presence and absence of CSE 
(Fig. 4G). Immunofluorescence staining demonstrated that 
enhanced expression of cytoplasmic ubiquitin, p62 and pro-
tein aggregations were induced in response to CSE exposure 
(Fig. 5G and M) and a marked enhancement of ubiquitin and 
p62 positive aggregations was observed in the presence of bafilo-
mycin A (Fig. 5I–K and O–Q ). Torin1 clearly suppressed accu-
mulations of p62 and ubiquitinated protein (Fig. 5H and N). 
The changes of cytoplasmic accumulation in response to CSE 
and autophagy regulation occurred similarly in both ubiqui-
tin and p62. Taken together, these data support an important 
regulatory role for autophagy in the clearance of ubiquitinated 
aggregates via a p62-mediated pathway.
Autophagy regulates the senescence-associated secretory 
phenotype of IL-8 expression in human bronchial epithelial 
cells. We evaluated IL-8 secretion in response to CSE exposure, 
since increased IL-8 secretion is known to be associated with cell 
senescence.5 CSE significantly induced the secretion of IL-8 and 
IL-8 secretion was enhanced in the presence of bafilomycin A 
(Fig. 6A). Autophagic regulation of IL-8 secretion was further 
demonstrated by siRNA-mediated knock down of LC3B, which 
showed clearly enhanced IL-8 secretion in response to CSE expo-
sure (Fig. 6B).
Impaired autophagy induction in response to CSE expo-
sure in HBEC from COPD patients. We have compared base-
line activity and induction of autophagy in response to CSE 
exposure in HBEC. Our results suggest that autophagy may 
play a role in COPD pathogenesis. Initially, we compared cell 
proliferation, senescence and oxidative stress, respectively, in 
HBEC (Table 1). Cell proliferation tended to be increased in 
HBEC from non-COPD smokers compared with HBEC from 
non-smokers and COPD patients (Fig. 7A). In contrast, carbon-
ylated proteins were increased in HBEC from COPD patients 
compared with HBEC from non-COPD patients, reflect-
ing increased oxidative stress (published data).24 However, 
there were no significant differences in p21 expression levels 
(Fig. 7B). Baseline autophagy activity (without CSE treatment) 
in HBEC from COPD patients was significantly increased 
compared with those of HBEC from non-smokers and non-
COPD smokers (Fig. 7C). In contrast, autophagy induction 
in response to CSE exposure was significantly attenuated in 
HBEC from COPD patients compared with that in HBEC 
from non-smokers and non-COPD smokers (Fig. 7D). To fur-
ther elucidate the functional status of autophagy in lung tis-
sue, we evaluated the expression levels of ubiquitinated proteins 
and p62 in lung homogenates from non-smokers, non-COPD 
smokers and COPD patients. Relatively high accumulations of 
Autophagy activation regulates CSE-induced cell senescence 
in human bronchial epithelial cells. To elucidate the regula-
tory role of autophagy in CSE-induced HBEC senescence, we 
used 3MA and Torin1 as an inhibitor and an inducer of autoph-
agy, respectively. 3MA inhibited autophagy flux and Torin1, a 
selective and potent small molecule inhibitor of mTOR, effec-
tively induced autophagy (Fig. 2A).17 CSE (1.0%) significantly 
increased the percentage of senescent cells as measured by both 
an increase in phospho-Histone H2A.X (Ser139) staining of 
DNA damage and by SA-β-Gal staining, which were enhanced 
in the presence of 3MA, an autophagic sequestration blocker 
(Fig. 2B and C). Western blotting for p21/waf-1, a senescence-
associated cyclin-dependent kinase inhibitor, also demonstrated 
enhanced expression with CSE treatment, particularly in the 
presence of 3MA (Fig. 2D). In contrast, Torin1 suppressed 
CSE-induced HBEC senescence since it significantly reduced 
phospho-Histone H2A.X (Ser139) staining, SA-β-Gal staining, 
and p21/waf-1 expression (Fig. 2B–D). Interestingly, 3MA alone 
induced HBEC senescence to the similar extent as CSE exposure 
(Fig. 2C and D). To further clarify the direct link between func-
tional impairment of autophagy and HBEC senescence, a time 
course of 3MA effect on HBEC senescence was evaluated with-
out CSE exposure. 3MA significantly increased the percentage 
of SA-β-Gal positive staining in a time dependent manner and 
3MA-mediated autophagy inhibition was confirmed by accumu-
lations of p62 (Fig. 2E).
Next, HBEC were transfected with siRNA to LC3B, which 
inhibits autophagosome formation. RT-PCR and western blot-
ting of HBEC showed that LC3B siRNA efficiently reduced 
both mRNA and protein levels of LC3B (Fig. 3A). Knockdown 
of LC3 was further confirmed by the lack of dot formation of 
EGFP-LC3 in stably transfected BEAS-2B cells (data not shown). 
Knockdown of LC3B resulted in an increased percentage of senes-
cent cells in response to CSE treatment in HBEC as determined 
by an increase in SA-β-Gal staining (Fig. 3B) and p21/waf-1 
expression (Fig. 3C). LC3B knockdown alone also enhanced cell 
senescence in the absence of CSE treatment (Fig. 3B and C). To 
further confirm the involvement of autophagy, HBEC were also 
transfected with siRNA to ATG5, which is an essential compo-
nent for autophagy. In concordance with the data of LC3 siRNA, 
ATG5 knockdown significantly enhanced CSE-induced HBEC 
senescence by means of SA-β-Gal staining (Fig. 3E) and p21/
waf-1 expression (Fig. 3F), suggesting that autophagy activation 
negatively regulates CSE-induced HBEC senescence.
Autophagy regulates accumulations of ubiquitinated pro-
tein and p62 in response to CSE exposure. We next examined 
the changes of expression levels of ubiquitinated proteins and 
p62 as indicator for autophagic clearance during CSE treatment. 
CSE (1.0%) induced accumulation of both ubiquitinated pro-
teins and p62 in a time dependent manner, especially after 24 h 
incubation, which corresponds to a decline of autophagy activity 
(Figs. 1C and 4A). Degradation of ubiquitinated proteins and 
p62 was inhibited by bafilomycin A, LC3B and ATG5 knock 
down (Fig. 4B–D). Conversely, Torin1 clearly reduced the accu-
mulations of ubiquitinated proteins and p62 in response to CSE 
exposure (Fig. 4B).
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(Fig. 7E and Table 2). Importantly, no significant age-related 
differences were observed between each group (Tables 1 and 2). 
Taken together, these data suggest that insufficient autophagy 
activation in response to cigarette smoke exposure may be 
ubiquitinated proteins and p62 were detected in lung homog-
enates from COPD patients, compared with those detected 
in lung homogenates from heavy smokers (Brinkman index ≥ 
900) and non-smokers/light smokers (Brinkman index < 900) 
Figure 2. Involvement of autophagy in 
regulation of cse-induced hBec senes-
cence. (a) The left part is western blotting 
(WB) using anti-Lc3 and anti-β-actin 
in control treated (lanes 1 and 2) and 
3Ma treated (1 mM) (lanes 3 and 4) and 
in the presence or absence of protease 
inhibitors (e64d 10 μg/ml and pepstatin 
a 10 μg/ml) in hBec. The right part is 
western blotting (WB) using anti-Lc3 and 
anti-β-actin in control treated (lanes 1 
and 2) and Torin1 (250 nM) treated (lanes 
3 and 4) in the presence or absence of 
protease inhibitors (e64d 10 μg/ml and 
pepstatin a 10 μg/ml) in hBec. protein 
samples were collected after a 24 h 
treatment. shown is a representative 
experiment of three similar results. (B) 
photographs of immunofluorescent stain-
ing of phospho-histone h2a.X (ser139) 
(upper parts), hoechst 33258 staining 
(middle parts) and senescence associated 
β-galactosidase (sa-β-gal) staining (lower 
parts) of control or cse (1.0% for 48 h) 
treated hBec in the presence or absence 
of 3Ma (1.0 mM) and Torin1 (250 nM). 
hoechst 33258 staining corresponds to 
phospho-histone h2a.X staining. Bar = 50 
μm in IF and 100 μm in sa-β-gal staining. 
(c) shown in left part is the percentage 
(± seM) of sa-β-gal positive cells from 
three independent experiments. Open 
bar is no treatment and filled bar is cse 
(1.0% for 48 h) treated in hBec. *p < 0.05. 
**p < 0.001. shown in right part is the 
percentage (± seM) of phospho-histone 
h2a.X (ser139) positive cells from three 
independent experiments. Open bar is no 
treatment and filled bar is cse (1.0% for 
48 h) treated in hBec. *p < 0.05. (D) West-
ern blot (WB) using anti-p21 or β-actin in 
control treated (lane 1), cse treated (lane 
2), control treated in the presence of 3Ma 
(1.0 mM) (lanes 3 and 4), cse treated in the 
presence of 3Ma (1 mM) (lanes 5 and 6), 
and cse treated in the presence of torin1 
(lanes 7 and 8) in hBec. protein samples 
were collected after 48 h treatment with 
cse. shown is a representative experi-
ment of three similar results. (e) WB using 
anti-p62 or anti-β-actin of cell lysates 
from hBec for indicated time points of 
control or 3Ma (1 mM) treatment (upper 
parts). sa-β-gal staining of indicated time 
points after 3Ma (1 mM) treatment in 
hBec. shown in lower part is the percent-
age (± seM) of sa-β-gal positive cells 
from three independent experiments. 
*p < 0.05.
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HBEC by CSE treatment. We consider that our findings can be 
understood to be an extension of recent interesting findings of 
autophagy induction in response to CSE exposure in associa-
tion with apoptosis and also speculate that the difference of CSE 
concentration was a critical determination for different cell fates 
between apoptosis and senescence.14,19 Our findings of simultane-
ous accumulations of p62 and ubiquitinated proteins after CSE 
treatment is of particular interest, because p62 accumulation 
has been recognized as a plausible hallmark of impairment or 
responsible for accumulation of ubiquiti-
nated proteins and p62 in lung homogenates 
from COPD patients.
Discussion
Although the molecular mechanisms for cel-
lular senescence is incompletely understood, 
intracellular protein and organelle degrada-
tion pathways, in terms of quality control, 
have been widely implicated in the regula-
tion of cell senescence. Accumulations of damaged cellular com-
ponents are proposed to be involved in the decline of cellular 
function, resulting in cell senescence.9,18 We show autophagy 
inhibition with both 3MA treatment or LC3 knockdown induced 
cell senescence, suggesting pivotal involvement of autophagy in 
the regulation of cell senescence in HBEC. Interestingly, we 
elucidated that the CSE-mediated activation of autophagy was 
transient and that insufficient autophagic clearance, at least 
partly, accounted for an increase in the percentage of senescent 
Figure 3. effect of Lc3 and aTG5 knock down on 
cse-induced cell senescence in hBec. (a) RT-pcR 
(upper part), using primers to Lc3B and β-actin, 
was performed from total RNa harvested from 
control siRNa (lane 1) and Lc3B siRNa (lane 2) 
transfected hBec after 48 h incubation. WB 
(lower part) using Lc3 and anti-β-actin of cell 
lysates from control siRNa (lane 1) and Lc3 siRNa 
(lane 2) transfected hBec after 48 h in the pres-
ence of protease inhibitors (e64d 10 μg/ml and 
pepstatin a 10 μg/ml). (B) senescence associated 
β-galactosidase (sa-β-gal) staining of control 
or Lc3B siRNa transfected hBec. shown in part 
is the percentage (± seM) of sa-β-gal positive 
cells from three independent experiments. Open 
bar is no treatment and filled bar is cse (1.0% for 
48 h) treated and horizontal crosshatched bar is 
cse (2.5% for 48 h) treated. *p < 0.05. (c) Western 
blot (WB) using anti-p21 or β-actin in control or 
Lc3B siRNa transfected hBec. hBec were treated 
with control (lanes 1 and 4), cse (1.0%) (lanes 
2 and 5) and cse (2.5%) (lanes 3 and 6). protein 
samples were collected after 48 h treatment 
with cse. shown is a representative experiment 
of 3 showing similar results. (D) Western blot 
(WB) using aTG5 and anti-β-actin of cell lysates 
from control siRNa (lane 1) and aTG5 siRNa (lane 
2) transfected hBec after 48 h. (e) senescence 
associated β-galactosidase (sa-β-gal) stain-
ing of control or aTG5 siRNa transfected hBec. 
shown in part is the percentage (± seM) of 
sa-β-gal positive cells from three independent 
experiments. Open bar is no treatment and filled 
bar is cse (1.0% for 48 h) treated. *p < 0.05. (F) 
Western blot (WB) using anti-p21 or β-actin in 
control or aTG5 siRNa transfected hBec. hBec 
were treated with control (lanes 1 and 3) and 
cse (1.0%) (lanes 2 and 4) and cse (2.5%) (lanes 
3 and 6). protein samples were collected after 48 
h treatment with cse. shown is a representative 
experiment of three similar results.
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Figure 4. accumulations of ubiquitinated protein and p62 in response to cse exposure in hBec. (a) WB using anti-ubiquitin, anti-p62 or anti-β-actin 
of cell lysates from hBec for indicated time points of control or cse (1.0%) treatment. shown is a representative experiment of 3 showing similar 
results. (B) WB using anti-ubiquitin, anti-p62 or anti-β-actin. hBec were exposed to cse (1.0% for 48 h) in the absence (lanes 1 and 2) or presence of to-
rin1 (250 nM) (lanes 3 and 4) and bafilomycin a (200 nM) (lanes 5 and 6). (c) WB using anti-ubiquitin, anti-p62 or anti-β-actin of cell lysates from control 
siRNa or Lc3B siRNa transfected hBec. cse (1.0% for 48 h) treatment was started 24 h post-siRNa transfection. (D) WB using anti-ubiquitin, anti-p62 or 
anti-β-actin of cell lysates from control siRNa or aTG5 siRNa transfected hBec. cse (1.0% for 48 h) treatment was started 24 h post-siRNa transfection. 
(e) RT-pcR (upper part), using primers to p62 and β-actin, was performed from total RNa harvested from control siRNa (lane 1) and p62 siRNa (lane 2) 
transfected hBec after 48 h incubation. WB (lower part) using anti-p62 and anti-β-actin of cell lysates from control siRNa (lane 1) and p62 siRNa (lane 
2) transfected hBec after 48 h incubation. shown is a representative experiment of 3 showing similar results. (F) WB using anti-ubiquitin and anti-β-
actin of cell lysates from control siRNa or p62 siRNa transfected hBec. cse (1.0% for 48 h) treatment was started 24 h post-siRNa transfection. In the 
lower part is the average (± se) taken from densitometric analysis of WB of four independent experiments shown as relative expression of ubiquitin 
compared with β-actin. Open bar is no treatment and filled bar is cse (1% for 48 h). (G) shown in part is the percentage (± seM) of sa-β-gal positive 
cells from three independent experiments. Open bar is no treatment and filled bar is cse (1.0% for 48 h) treated hBec. ns = not significant.
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pathological increase of endoplasmic reticulum (ER) stress and 
apoptosis.20 Our in vitro experiments demonstrated accumula-
tions of ubiquitin-conjugated protein in response to CSE expo-
sure, which were clearly enhanced by inhibition of autophagy 
and decreased by Torin1-mediated activation of autophagy. 
Simultaneous accumulations of ubiquitinated proteins and p62 
support the notion that not only decreased proteasome activity 
but also impairment of autophagic degradation is responsible for 
the accumulations of ubiquitinated proteins. Knock-down of LC3 
enhanced accumulations of both ubiquitinated proteins and p62 
even without exposure to CSE (Fig. 6C), suggesting the pivotal 
role of LC3 for autophagic degradation of ubiquitinated proteins 
deficiency of autophagy, in the setting of selective degradation of 
ubiquitinated proteins.13
Ubiquitinated proteins are originally designated for proteo-
lytic degradation in the proteasome system, a multicatalytic com-
plex, which is major intracellular proteolytic machinery and is 
also responsible for a diverse array of cell functions and fates.10 
It remains likewise unresolved whether proteasome activity sim-
ply declines with aging. However, accumulation of ubiquitin-
conjugated proteins is an age-related feature of senescent cells, 
especially in pathological conditions such as neurodegenerative 
disorders.13 Recently, impairment of proteasome activity has 
been demonstrated in COPD lung, which was associated with 
Figure 5. Immunofluorescence staining of ubiquitin and p62 in hBec. photomicrographs of nuclear staining with hoechst 33258 (a–e), immunofluo-
rescence staining with anti-ubiquitin (F–K) and anti-p62 (L–Q). hBec were control treated (a, F and L) or cse (1.0%) treated (B, c, e, G, h, J, K, M, N, p and 
Q), in the presence of Torin1 (250 nM) (c, h and N) or bafilomycin a (200 nM) (D, e, I–K, O–Q). all photomicrographs are taken at the same magnifica-
tion. Original magnification is 200×. Bar = 50 μm. (K and Q) are high magnification view.
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autophagosomes in alveolar macrophages from smok-
ers.21 However, our observations of elevated LC3-II 
conversion in HBEC in the absence of CSE exposure 
were detected only in the presence of in vitro prote-
ase inhibitors, demonstrating an increase of baseline 
autophagy flux in HBEC from COPD patients, sug-
gesting the potential for increased autophagy in COPD 
lung in our system. Practically, detection of LC3-II by 
western blotting in the presence of protease inhibitors 
(E64d and pepstatin A) to prevent further degradation 
is a standard method to precisely evaluate the activa-
tion of autophagy flux, especially in in vitro culture 
models.16 It is attractive to superimpose the oxidant/
antioxidant imbalance theory in COPD pathogenesis 
on the mechanisms for increased baseline autophagy 
flux.22 We postulate that HBEC from COPD patients 
are already stressed by both extrinsic and intrinsic 
ROS by several mechanisms, including insufficient 
amounts of anti-oxidant proteins and excessive oxi-
dant release from damaged mitochondria,23 even after 
smoking cessation, resulting in increase of baseline 
autophagy. In support of this notion, carbonylated 
proteins, reflecting oxidative stress, were apparently 
increased in HBEC from COPD patients compared 
with those from non-COPD patients.24
In spite of increased baseline activity, the accumulations of 
ubiquitinated proteins and p62 in COPD lung homogenates 
may be explained by insufficient autophagic clearance of smok-
ing-induced damaged cellular compartments in COPD lungs 
(Fig. 7C). It is likely that the attenuation of autophagy flux in 
response to CSE exposure may reflect an insufficient reserve of 
autophagy activation in HBEC from COPD patients, resulting in 
accumulations of ubiquitinated-protein and p62. Accumulations 
of ubiquitinated protein and p62 were also demonstrated in 
response to CSE in alveolar macrophages from non-smokers and 
also in alveolar macrophages from smokers without CSE expo-
sure, indicating that HBEC and alveolar macrophages may, at 
least partly, share similar mechanisms of impairment for induc-
tion of autophagic degradation, which is potentially involved 
in the pathogenic sequence of COPD.21 Interestingly, a recent 
paper demonstrated that ROS-mediated SUMOylation of trans-
glutaminase was responsible for autophagy inhibition through 
downregulation of beclin1 in airway epithelial cells, however 
whether this is a cystic fibrosis-specific mechanism remains to 
be elucidated.25
Accelerated cellular senescence has been widely implicated 
in the pathogenesis of COPD in terms of both impaired cell 
repopulation and aberrant cytokine secretions of SASP.2-4 
Autophagy inhibition with bafilomycin A and LC3B knock-
down with CSE treatment clearly enhanced IL-8 secretion 
in conditioned medium, which appeared to be correspond-
ing to the accelerated cellular senescence accompanied by 
SASP. Conversely, autophagy has also been demonstrated 
to be activated during senescence progression and aggres-
sively contributes to the development of cellular senescence 
with SASP of cytokine secretions including IL-6 and IL-8 in 
through p62 binding, which is consistent with prior reports.13 
In contrast, p62 knockdown demonstrated no clear impact on 
baseline levels of ubiquitinated proteins, suggesting that p62 is 
mainly employed for the degradation of stress-induced ubiquiti-
nated proteins and that different types of adaptor protein might 
also exist for autophagic degradation of ubiquitinated proteins in 
physiological conditions.
Increase in LC3-II/LC3-I has been reported in COPD lung 
tissues, which are recognized as markers for increased activation 
of autophagy.14 Accordingly, we have also performed anti-LC3 
western blotting using lung homogenates. However, LC3-II 
expression in lung homogenates was not detected, regardless of 
diagnosis (data not shown). We speculate that LC3-II is rapidly 
processed in lung tissue in the absence of protease inhibitors in 
our system.16 Furthermore, LC3-II bands were barely detected in 
the absence of protease inhibitors in cultured HBEC. Previous 
studies demonstrated high levels of baseline LC3-II conversion 
in COPD lung, which was due to a decrease in the processing of 
Figure 6. IL-8 secretion by autophagy inhibition in cse-induced senescent hBec. For 
preparation of the conditioned medium, hBec were treated with cse (1.0%) in the 
absence or presence of Torin1 (250 nM) and bafilomycin a (200 nM) for 24 h, washed 
three times with pBs, then incubated in fresh BeGM for 48 h. (a) eLIsa showing IL-8 
in conditioned media with or without cse-treatment in the absence (lanes 1 and 2), 
or presence of Torin1 (lanes 3 and 4) and bafilomycin a (lanes 5 and 6). shown is the 
arbitrary units ± seM *p < 0.05. **p < 0.001. (B) eLIsa showing IL-8 in conditioned 
media from control siRNa (lanes 1 and 2) or Lc3B siRNa (lanes 3 and 4) transfected 
hBec. cse (1.0% for 48 h) treatment was started 24 h post-siRNa transfection. shown 
is the arbitrary units ± seM *p < 0.05.
Table 1. patient characteristics (for hBec)
Non-smoker 
(n = 5)
Non-COPD 
smoker (n = 5)
COPD  
(n = 5)
p value
age, years 63.8 ± 14.2 67.2 ± 8.2 66.0 ± 4.8 Ns
Male, % of 
group
20 80 100 Na
Brinkman 
Index
0 518 ± 374.4 1010 ± 391.2 Na
FeV1/FVc 73.8 ± 3.9 79.1 ± 1.3 60.2 ± 12.7 Na
abbreviations: cOpD, chronic obstructive pulmonary disease; FeV1, 
forced expiratory volume in 1 second; FVc, forced vital capacity; Na, not 
assessed; Ns, not statistically significant. Values are mean ± sD.
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for the upregulation of inflammatory cytokines via activation 
of NFκB,27 and NFκB is also involved in the regulation of 
cell senescence.28 Although p62 knock down delineated the 
the setting of oncogene-induced 
senescence (OIS) in human fibro-
blasts.5 Autophagy-mediated pro-
tein turnover has been postulated 
to be necessary for active protein 
synthesis of these cytokines, which 
are required for the execution and 
maintenance of OIS.26 In our sys-
tem, autophagy-mediated protein 
turnover seems to be unimport-
ant for senescence progression 
and IL-8 secretion, suggesting the nature of autophagy in 
cell senescence regulation is cell-type or inducer-specific. 
Interestingly, p62 has also been demonstrated to be responsible 
Figure 7. autophagy activity in hBec 
and lung homogenates from cOpD 
patients. (a) Ki67 staining. shown in 
part is the average percentage (±seM) 
of Ki67 positive cells in hBec isolated 
from non-smoker (n = 5), smoker 
without cOpD (n = 5) and cOpD (n = 5). 
(B) WB using anti-p21 and anti-β-actin 
of cell lysates from hBec isolated 
from nonsmokers (lanes 1–3), non-
cOpD smokers (lanes 4–6) and cOpD 
patients (lanes 7–9). The lower part is 
the average (± seM) taken from den-
sitometric analysis of WB. presented 
cases are non-smoker (n = 5), smoker 
without cOpD (n = 5) and cOpD (n = 5). 
(c) WB using anti-Lc3 and anti-β-actin 
without cse treatment in the pres-
ence of protease inhibitors (e64d and 
pepstatin a) in hBec from nonsmokers 
(lanes 1–3), non-cOpD smokers (lanes 
4–6) and cOpD patients (lanes 7–9). 
The lower part is the average (± seM) 
taken from densitometric analysis of 
WB. presented cases are non-smoker 
(n = 5), smoker without cOpD (n = 5) 
and cOpD (n = 5). (D) WB using anti-
Lc3 and anti-β-actin of control or cse 
(1.0%) treatment in the presence or 
absence of protease inhibitors (e64d 
and pepstatin a) in hBec (left part). 
The lower part is the average (± seM) 
of relative increase in Lc3-II normal-
ized to β-actin following cse exposure 
compared with control treated hBec 
in the presence of protease inhibitors, 
which are taken from densitometric 
analysis of WB. presented cases are 
non-smoker (n = 5), smoker without 
cOpD (n = 5) and cOpD (n = 5). (e) WB 
using anti-ubiquitin, anti-p62 or anti-
β-actin of lung homogenates from 
non-smoker (n = 3), smoker without 
cOpD (Brinkman Index < 900) (n = 3), 
smoker with cOpD (Brinkman Index ≧ 
900) (n = 3) and cOpD (n = 3). The right 
part is the average (± seM) taken from 
densitometric analysis of WB using 
anti-ubiquitin.
©
20
12
 L
an
de
s 
B
io
sc
ie
nc
e.
 D
o 
no
t d
is
tri
bu
te
.
639 OncoImmunology Volume 1 Issue 5
cultured in RPMI1640 with 10% FCS and penicillin-streptomy-
cin. Antibodies used were rabbit anti-LC3 (Novus), rabbit anti-
ATG5 (Novus), mouse anti-p21 (Cell signaling Technology), 
rabbit anti-phospho-histone H2A.X (Ser139) (Cell signaling 
Technology), mouse anti-poly and mono ubiquitin (Enzo Life 
Sciences), rabbit anti-p62 (MBL), and mouse anti-β-actin (Santa 
Cruz). Pepstatin A (Peptide Institute), E64d (Peptide Institute), 
Bafilomycin A (R&D Systems), 3-methyladenine (3-MA), 
an autophagic sequestration blocker, (Affinity BioReagents), 
rapamycin (Sigma Aldrich) and rat-tail type-I collagen (Sigma-
Aldrich) were purchased. Torin 1, a selective and potent small 
molecule inhibitor of mTOR as inducers of autophagy, was 
kindly provided by Drs Gray and Sabatini (Whitehead Institute).
Preparation of cigarette smoke extract. Cigarette smoke 
extract (CSE) was prepared as previously described with minor 
modifications.21 Forty milliliters of cigarette smoke was drawn 
into the syringe and slowly bubbled into sterile serum-free cell 
culture media in a 15-ml BD falcon tube. One cigarette was used 
for the preparation of 10 mL of solution. CSE solution was fil-
tered (0.22 μm) to remove insoluble particles and was designated 
as a 100% CSE solution.
SA-β-Gal staining. Senescence associated β-galactosidase 
(SA-β-Gal) staining was performed using HBEC (2 × 105) grown 
on 12-well culture plates according to the manufacturer’s instruc-
tions (β-galactosidase staining kit, BioVision Research Products).
Western blotting. HBEC grown on 12-well culture plates were 
treated with CSE for the indicated time points and lysed in RIPA 
buffer (Thermo Fisher Scientific) with protease inhibitor cocktail 
(Roche Diagnostics) and 1 mM sodium orthovanadate (Wako). 
HBEC were also lysed in Laemmli sample buffer for LC3 detec-
tion. Lung homogenates were prepared using a Bioruptor UCD250 
(Cosmo Bio) and sonication of lung tissue was performed accord-
ing to the manufacturer’s instructions. Western blotting was per-
formed as previously described with minor modification.1 After 
transfer to PVDF membrane (Immobilon-P, Millipore), blot-
ting with specific primary antibodies were performed overnight 
at 4°C. Proteins were detected by HRP-conjugated secondary 
antibody (Bethyl Laboratories) followed by chemiluminescence 
detection (ECL; GE Healthcare) with a LAS-4000 UV mini sys-
tem (Fujifilm). The conversion of LC3 from LC3-I (free form) to 
LC3-II (phosphatidylethanolamine-conjugated form) represents a 
key step in autophagosome formation15 and detection of LC3-II 
by western blotting in the presence of protease inhibitors (E64d 
and pepstatin A) to prevent further degradation is a standard 
method to evaluate the activation of autophagy.
tendency of senescence suppression (Fig. 4E), further studies 
are required to address the more direct involvement of p62 in 
the regulation of cell senescence and SASP.
In summary, we demonstrated the involvement of autophagy 
in the regulation of CSE-induced HBEC senescence and SASP. 
The accumulation of both ubiquitinated proteins and p62 suggest 
that induction of autophagic degradation of damaged proteins in 
response to CSE exposure might be a crucial determinant for cell 
senescence and insufficiency of autophagy is potentially involved 
in COPD pathogenesis. We understand the potential limitations 
of using large airway bronchial epithelial cells as an experimental 
model to elucidate the pathogenesis of small airway disease and 
emphysema, therefore more relevant cell culturing models using 
small airway epithelial cells or alveolar epithelial cells are needed 
in future studies to further confirm the physiological relevance 
of our results. However, our finding of an inhibitory effect of 
Torin 1 on CSE-induced accumulations of ubiquitinated protein 
and cellular senescence suggests that optimal levels of autophagy 
induction is a potentially effective medical intervention to reduce 
the accumulation of damaged proteins and organelles, resulting 
in amelioration of the tobacco smoking related senescence associ-
ated lung disease, COPD.
Material and Methods
Cell culture, antibodies and reagents. Normal and COPD air-
ways were collected from 1st through 4th order bronchi from 
pneumonectomy and lobectomy specimens from resections per-
formed for primary lung cancer. Informed consent was obtained 
from all surgical participants as part of an approved ongoing 
research protocol by the ethical committee of Jikei University 
School of Medicine. HBEC were isolated with protease treat-
ment and freshly isolated HBEC were plated onto rat-tail col-
lagen type I-coated (10 μg/ml) dishes, incubated overnight, 
and then the medium was changed to bronchial epithelial 
growth medium (BEGM, Clonetics). Cultures were character-
ized immunohistochemically using anti-cytokeratin antibodies 
(Lu-5, BioCare Medical) and anti-vimentin (Sigma-Aldrich), 
as previously described in reference 29. HBEC showed > 95% 
positive staining with anti-cytokeratin and < 5% positive stain-
ing with the anti-vimentin antibody (data not shown). HBEC 
were serially passaged and used for experiments until passage 3. 
The majority of experiments for autophagy induction and evalu-
ation of cell senescence were performed with HBEC from non-
COPD patients. Bronchial epithelial cell line BEAS-2B cells were 
Table 2. patient characteristics (for lung homogenates)
Non-smoke (n = 3)
Non-COPD smoker
COPD (n = 3) p value
BI < 900 (n = 3) BI ≥ 900 (n = 3)
age, years 60.3 ± 18 74.0 ± 1.73 62.3 ± 12.7 66.3 ± 7.6 Ns
Male, % of group 0 100 100 100 Na
Brinkman Index 0 506.7 ± 100.7 983.3 ± 76.4 1,030 ± 246.4 Na
FeV1/FVc 75.1 ± 5.1 75.1 ± 2.8 79.3 ± 0.8 62.1 ± 5.7 Na
abbreviations: BI, Brinkman index; cOpD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second; FVc, forced vital  
capacity; Na, not assessed; Ns, not statistically significant. Values are mean ± sD.
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and bafilomycin A, and washed three times with PBS. To collect 
the conditioned medium, HBEC were incubated in serum-free 
DMEM for 48 h in the presence or absence of Torin1 and bafilo-
mycin A respectively. CSE (1.0% for 48 h) treatment was started 
24 h post-siRNA transfection. Culture medium was collected 
from similarly treated cells. IL-8 was measured in conditioned 
media with an IL-8 Quantikine ELISA kit (R and D Systems).
Statistics. Data are shown as the average (±SEM) taken from 
at least three independent experiments. Student’s t-test was used 
for comparison of two data sets, analysis of variance for mul-
tiple data sets. Tukey’s or Dunn’s test were used for parametric 
and nonparametric data, respectively. Significance was defined 
as p < 0.05. Statistical software used was Prism v.5 (GraphPad 
Software, Inc.).
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cloned into pEGFP-C1 vector (Clontech).15 pEGFP-LC3 plas-
mid was transfected into Beas-2B cells using Lipofectamine 2000 
(Invitrogen) and stably expressing clones were selected by cul-
turing with G418 (1.0 mg/ml) containing medium. The p62, 
LC3B, ATG5, p21 and negative control siRNAs were purchased 
(Applied Biosystems) and transfections of HBEC were performed 
with the Amaxa Nucleofector (Lonza), using matched optimized 
transfection kits for airway epithelial cells.
RNA isolation, polymerase chain reaction. RNA isolation, 
reverse transcription and polymerase chain reaction were per-
formed as previously described. The primers used were LC3 sense 
primer, 5'-GAT GTC CGA CTT ATT CGA GAG C-3', LC3 
antisense primer, 5'-TTG AGC TGT AAG CGC CTT CTA-3'; 
p62 sense primer, 5'-CCA GTG ACG AGG AAT TGA CAA-
3', p62 antisense primer, 5'-CAT CGC AGA TCA CAT TGG 
GG-3'; β-actin sense primer, 5'-TGA CGG GGT CAC CCA 
CAC TGT GCC-3', β-actin antisense primer, 5'-CTA GAA 
GCA TTT GCG GTG GAC GAT GGA GGG-3'. These primer 
sets yielded PCR products of 167 bp, 156 bp and 662 bp for LC3, 
p62 and β-actin respectively. Aliquots of the PCR products were 
subjected to agarose gel electrophoresis in TRIS-acetate-EDTA 
buffer and visualized by ethidium bromide staining. Primer 
sequences for LC3 and p62 were from Primer Bank (http://pga.
mgh.harvard.edu/primerbank).
IL-8 enzyme-linked immunosorbent assay. HBEC were incu-
bated with 1.0% CSE for 24 h in the presence or absence of Torin1 
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